Cohort characteristics. by Vincent Pey (21433304)

“…</p><p>Results</p><p>Upon initiation of CPB we observed a significant decrease in arterial whole blood redox potential (101.90 mV + /- 11.52 vs. 41.80 mV + /- 10,26; p < 0.0001). …”

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

The small blue circles show the IC-volume (mean of left and right) from 72 males and the small red squares from 51 females as a function of age. by Pingling Kwok (14896191)

Antibiotic use in small animals by substance registration status. by Sarin Suwanpakdee (119683)

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

A deidentified raw data set is attached to this manuscript, providing soluble IL-6 and sIL-6r levels, as well as SNP allele statuses. by Kyle D. Anderson (2296873)

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. by Farayi Kaseke (19560197)

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Relationship of risk score with immune status. by Yajia Chen (20685780)

Supplementary Material for: The current status of tumor markers as biomarkers in the era of immunotherapy for hepatocellular carcinoma: alpha-fetoprotein alone is not sufficient by Hiraoka A. (4273894)

“…Since immune therapy shows a favorable therapeutic efficacy, use of tumor markers as biomarkers for monitoring treatment response is necessary. …”

Flow chart. by Raphaele Houlbracq (20558509)

Subjects:

CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Image 7_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”

Image 6_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”

Image 1_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”

Image 3_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”

Image 5_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”

Image 4_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.pdf by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”

Table 1_Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis.docx by Hui Zhang (7197)

“…Our main outcomes were nutritional status and markers of inflammation analyzed using a random-effects model.…”